Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


04.12.2017

4 Acta Obstet Gynecol Scand
5 Am J Obstet Gynecol
2 Am J Surg Pathol
2 Ann Oncol
8 Anticancer Res
1 Aust N Z J Obstet Gynaecol
11 BMJ
1 Br J Cancer
1 Br J Radiol
1 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
1 Eur J Cancer
3 Eur J Obstet Gynecol Reprod Biol
5 Fertil Steril
7 Gynecol Endocrinol
18 Gynecol Oncol
4 Hum Reprod
2 Int J Cancer
3 Int J Gynaecol Obstet
1 JAMA
3 Lancet
4 Obstet Gynecol
1 Oncogene
5 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. MESSERLIAN C, Basso O
    Cohort studies in the context of obstetric and gynecologic research: a methodologic overview.
    Acta Obstet Gynecol Scand. 2017 Dec 1. doi: 10.1111/aogs.13272.
    PubMed     Text format     Abstract available

  2. LAINE MK, Kautiainen H, Gissler M, Raina M, et al
    Gestational diabetes in primiparous women - impact of age and adiposity: a register-based cohort study.
    Acta Obstet Gynecol Scand. 2017 Dec 1. doi: 10.1111/aogs.13271.
    PubMed     Text format     Abstract available

  3. KREUNINGER JA, Cohen SL, Meurs EA, Cox M, et al
    Trends in readmission rate by route of hysterectomy - A single center experience.
    Acta Obstet Gynecol Scand. 2017 Nov 29. doi: 10.1111/aogs.13270.
    PubMed     Text format     Abstract available

  4. STEPHANSSON O, Petersson K, Bjork C, Conner P, et al
    The Swedish Pregnancy Register - for Quality of Care Improvement and Research.
    Acta Obstet Gynecol Scand. 2017 Nov 24. doi: 10.1111/aogs.13266.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  5. ROSER BJ, Rubin SE, Nagarajan N, Wieland DL, et al
    A Data Extraction Algorithm for Assessment of Contraceptive Counseling and Provision.
    Am J Obstet Gynecol. 2017 Nov 23. pii: S0002-9378(17)32345.
    PubMed     Text format     Abstract available

  6. WATSON HA, Ridout A, Shennan AH
    Second stage caesarean as risk factor for preterm birth: how to manage subsequent pregnancies?
    Am J Obstet Gynecol. 2017 Nov 23. pii: S0002-9378(17)32372.
    PubMed     Text format    

  7. TOMAO F, Panici PB, Tomao S
    Progesterone therapy in endometrial cancer.
    Am J Obstet Gynecol. 2017 Nov 23. pii: S0002-9378(17)32366.
    PubMed     Text format    

  8. MANCHANDA R, Patel S, Antoniou AC, Levy-Lahad E, et al
    Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
    Am J Obstet Gynecol. 2017;217:578.
    PubMed     Text format     Abstract available

  9. GRIMES CL, Patankar S, Ryntz T, Philip N, et al
    Evaluating ureteral patency in the post-indigo carmine era: a randomized controlled trial.
    Am J Obstet Gynecol. 2017;217:601.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  10. NA K, Kim HS
    Clinicopathologic and Molecular Characteristics of Mesonephric Adenocarcinoma Arising From the Uterine Body.
    Am J Surg Pathol. 2017 Nov 17. doi: 10.1097/PAS.0000000000000991.
    PubMed     Text format     Abstract available

  11. DALTON LW
    Discordance in Pathologist Assessment of Endometrial Cancer is Informative While Level of Discordance of Molecular Classification Remains Unknown.
    Am J Surg Pathol. 2017 Nov 15. doi: 10.1097/PAS.0000000000000904.
    PubMed     Text format    


    Ann Oncol

  12. PROVENCHER DM, Gallagher CJ, Parulekar WR, Ledermann JA, et al
    OV21/PETROC: A randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.
    Ann Oncol. 2017 Nov 23. pii: 4654091. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. DE BOER SM, Wortman BG, Bosse T, Powell ME, et al
    Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
    Ann Oncol. 2017 Nov 27. pii: 4668721. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  14. KUITTINEN T, Rovio P, Staff S, Luukkaala T, et al
    Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro.
    Anticancer Res. 2017;37:6575-6581.
    PubMed     Text format     Abstract available

  15. NA K, Sung JY, Kim HS
    TP53 Mutation Status of Tubo-ovarian and Peritoneal High-grade Serous Carcinoma with a Wild-type p53 Immunostaining Pattern.
    Anticancer Res. 2017;37:6697-6703.
    PubMed     Text format     Abstract available

  16. KOENSGEN D, Besic I, Gumbel D, Kaul A, et al
    Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer Therapy.
    Anticancer Res. 2017;37:6739-6744.
    PubMed     Text format     Abstract available

  17. DUCOULOMBIER S, Golfier F, Colomban O, Benayoun D, et al
    Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer.
    Anticancer Res. 2017;37:6879-6886.
    PubMed     Text format     Abstract available

  18. TINELLI G, Cappuccio S, Parente E, Fagotti A, et al
    Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series.
    Anticancer Res. 2017;37:6899-6906.
    PubMed     Text format     Abstract available

  19. MOURAD WF, Packianathan S, Yan W, Pishgou M, et al
    Reliable Radiation Technique to Minimize Ovarian Dose During Radiation Prophylaxis of Heterotopic Ossification.
    Anticancer Res. 2017;37:6929-6935.
    PubMed     Text format     Abstract available

  20. NIIBE Y, Onda T, Matsuo K, Inoue Y, et al
    Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
    Anticancer Res. 2017;37:6983-6988.
    PubMed     Text format     Abstract available

  21. LEE HJ, Lee YH, Chong GO, Hong DG, et al
    Robotic-assisted Transperitoneal Infrarenal Para-aortic Lymphadenectomy for Gynecological Malignancies: Comparison with a Laparoscopic Approach.
    Anticancer Res. 2017;37:7087-7093.
    PubMed     Text format     Abstract available


    Aust N Z J Obstet Gynaecol

  22. ANDERSSON L, Szabo F
    The incidence and outcome of clinically significant antibodies detected in Rhesus-D positive pregnant women of the Northern Territory.
    Aust N Z J Obstet Gynaecol. 2017 Nov 28. doi: 10.1111/ajo.12750.
    PubMed     Text format     Abstract available


    BMJ

  23. JOHNSON AP, Hughes G
    The prospect of untreatable gonorrhoea.
    BMJ. 2017;358:j3973.
    PubMed     Text format    

  24. BARRETT J
    Gender dysphoria: assessment and management for non-specialists.
    BMJ. 2017;357:j2866.
    PubMed     Text format    

  25. GULLAND A
    Items dispensed in England rise sharply in 10 years.
    BMJ. 2017;357:j3172.
    PubMed     Text format    

  26. IACOBUCCI G
    Free condoms should be targeted at people with high STI risk, says NICE.
    BMJ. 2017;357:j1751.
    PubMed     Text format    

  27. ROTH DE, Leung M, Mesfin E, Qamar H, et al
    Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials.
    BMJ. 2017;359:j5237.
    PubMed     Text format     Abstract available

  28. HICKEY M, Szabo RA, Hunter MS
    Non-hormonal treatments for menopausal symptoms.
    BMJ. 2017;359:j5101.
    PubMed     Text format    

  29. HOWARD S
    After 50 years of legal abortion in Great Britain, calls grow for further liberalisation.
    BMJ. 2017;359:j5278.
    PubMed     Text format    

  30. RILEY RD, Jackson D, Salanti G, Burke DL, et al
    Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
    BMJ. 2017;358:j3932.
    PubMed     Text format    

  31. MISTRY VN, Suida MI, Kirkham D, Ho MWS, et al
    An atypical, non-healing perioral lesion.
    BMJ. 2017;358:j3823.
    PubMed     Text format    

  32. SINGH MM, Devi R
    Time to rethink the syndromic approach to sexually transmitted infections.
    BMJ. 2017;358:j3789.
    PubMed     Text format    

  33. ELANGASINGHE MA
    Considering syphilis and HIV in differential diagnoses.
    BMJ. 2017;358:j3633.
    PubMed     Text format    


    Br J Cancer

  34. SEAMON LG, Java JJ, Monk BJ, Penson RT, et al
    Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
    Br J Cancer. 2017 Nov 28. pii: bjc2017400. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Radiol

  35. HAMED ST, Mansour SM
    Surface transperineal ultrasound and vaginal abnormalities: Applications and strengths.
    Br J Radiol. 2017 Sep 13:20170326. doi: 10.1259/bjr.20170326.
    PubMed     Text format     Abstract available


    Cancer Lett

  36. TOMAR S, Plotnik JP, Haley J, Scantland J, et al
    ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase.
    Cancer Lett. 2017;414:190-204.
    PubMed     Text format     Abstract available


    Cancer Res

  37. HIRAMATSU K, Serada S, Enomoto T, Takahashi Y, et al
    LSR antibody therapy inhibits ovarian epithelial tumor growth by inhibiting lipid uptake.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0910.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  38. PENG G, Mills GB
    Surviving ovarian cancer: an affair between defective DNA repair and RB1.
    Clin Cancer Res. 2017 Nov 30. pii: 1078-0432.CCR-17-3022.
    PubMed     Text format     Abstract available

  39. NORQUIST BM, Brady MF, Harrell MI, Walsh T, et al
    Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: an NRG Oncology/Gynecologic Oncology Group Study.
    Clin Cancer Res. 2017 Nov 30. pii: 1078-0432.CCR-17-1327.
    PubMed     Text format     Abstract available


    Eur J Cancer

  40. TIMMERMANS M, Sonke GS, Van de Vijver KK, van der Aa MA, et al
    No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
    Eur J Cancer. 2017;88:31-37.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  41. VAN IJSSELMUIDEN MN, Detollenaere RJ, Gerritse MBE, Kluivers KB, et al
    Dutch women's attitudes towards hysterectomy and uterus preservation in surgical treatment of pelvic organ prolapse.
    Eur J Obstet Gynecol Reprod Biol. 2017;220:79-83.
    PubMed     Text format     Abstract available

  42. BACA KM, Govil M, Zmuda JM, Simhan HN, et al
    Vitamin D metabolic loci and vitamin D status in Black and White pregnant women.
    Eur J Obstet Gynecol Reprod Biol. 2017;220:61-68.
    PubMed     Text format     Abstract available

  43. ALI A, Shastry S, Nithiyananthan R, Ali A, et al
    Gestational diabetes-Predictors of response to treatment and obstetric outcome.
    Eur J Obstet Gynecol Reprod Biol. 2017;220:57-60.
    PubMed     Text format     Abstract available


    Fertil Steril

  44. BLUMENFELD Z
    Ovarian tissue transplantation in leukemia.
    Fertil Steril. 2017 Nov 23. pii: S0015-0282(17)31965.
    PubMed     Text format    

  45. CHO K, Dunne C, Albert AYK, Havelock JC, et al
    Adverse perinatal outcomes associated with crown-rump length discrepancy in in vitro fertilization pregnancies.
    Fertil Steril. 2017 Nov 28. pii: S0015-0282(17)31959.
    PubMed     Text format     Abstract available

  46. MENG F, Zapantis G, Williams SZ, Lieman HJ, et al
    Status of nucleolar channel systems in uterine secretions accurately reflects their prevalence-a marker for the window of implantation-in simultaneously obtained endometrial biopsies.
    Fertil Steril. 2017 Nov 23. pii: S0015-0282(17)31975.
    PubMed     Text format     Abstract available

  47. KAPFHAMER JD, Palaniappan S, Summers K, Kassel K, et al
    Difference between mean gestational sac diameter and crown-rump length as a marker of first-trimester pregnancy loss after in vitro fertilization.
    Fertil Steril. 2017 Nov 23. pii: S0015-0282(17)31964.
    PubMed     Text format     Abstract available

  48. VITAGLIANO A, Noventa M, Saccone G, Gizzo S, et al
    Endometrial scratch injury before intrauterine insemination: is it time to re-evaluate its value? Evidence from a systematic review and meta-analysis of randomized controlled trials.
    Fertil Steril. 2017 Nov 23. pii: S0015-0282(17)31954.
    PubMed     Text format     Abstract available


    Gynecol Endocrinol

  49. BONACCORSI G, Messina C, Cervellati C, Maietti E, et al
    Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.
    Gynecol Endocrinol. 2017 Nov 24:1-5. doi: 10.1080/09513590.2017.1407308.
    PubMed     Text format     Abstract available

  50. WASNIEWSKI T, Woclawek-Potocka I
    Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology.
    Gynecol Endocrinol. 2017 Nov 28:1-6. doi: 10.1080/09513590.2017.1409707.
    PubMed     Text format     Abstract available

  51. HU Y, Wen S, Yuan D, Peng L, et al
    The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2017 Nov 30:1-8. doi: 10.1080/09513590.2017.1405931.
    PubMed     Text format     Abstract available

  52. MERTOGLU C, Gunay M, Gul V, Kulhan M, et al
    Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?
    Gynecol Endocrinol. 2017 Nov 29:1-4. doi: 10.1080/09513590.2017.1409710.
    PubMed     Text format     Abstract available

  53. ZHAO Y, Sun H, Feng M, Zhao J, et al
    Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling.
    Gynecol Endocrinol. 2017 Nov 28:1-5. doi: 10.1080/09513590.2017.1409714.
    PubMed     Text format     Abstract available

  54. SONG J, Ruan X, Gu M, Wang L, et al
    Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Gynecol Endocrinol. 2017 Nov 24:1-5. doi: 10.1080/09513590.2017.1407752.
    PubMed     Text format     Abstract available

  55. SAHIN E, Eraslan Sahin M, Dolanbay M, Ozcelik B, et al
    Induction of apoptosis by metformin and progesterone in estrogen-induced endometrial hyperplasia in rats: involvement of the bcl-2 family proteins.
    Gynecol Endocrinol. 2017 Nov 27:1-4. doi: 10.1080/09513590.2017.1409708.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  56. TOZZI R, Casarin J, Garruto-Campanile R, Majd HS, et al
    Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
    Gynecol Oncol. 2017 Nov 20. pii: S0090-8258(17)31527.
    PubMed     Text format     Abstract available

  57. LEE YJ, Chung YS, Lee JY, Nam EJ, et al
    Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer.
    Gynecol Oncol. 2017 Nov 21. pii: S0090-8258(17)31532.
    PubMed     Text format     Abstract available

  58. HOROWITZ NS, Larry Maxwell G, Miller A, Hamilton CA, et al
    Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
    Gynecol Oncol. 2017 Nov 22. pii: S0090-8258(17)31371.
    PubMed     Text format     Abstract available

  59. GULERIA S, Jensen A, Kjaer SK
    Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
    Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31534.
    PubMed     Text format     Abstract available

  60. MOSS HA, Havrilesky LJ
    The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care.
    Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31507.
    PubMed     Text format     Abstract available

  61. BITLER BG, Watson ZL, Wheeler LJ, Behbakht K, et al
    PARP inhibitors: Clinical utility and possibilities of overcoming resistance.
    Gynecol Oncol. 2017;147:695-704.
    PubMed     Text format     Abstract available

  62. NOMURA H, Nagashima M, Aoki Y, Takeshima N, et al
    Resection of the inferior pubic ramus to completely remove locally advance adenoid cystic carcinoma of Bartholin's gland.
    Gynecol Oncol. 2017;147:723-724.
    PubMed     Text format     Abstract available

  63. PEI X, Xiang L, Ye S, He T, et al
    Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;147:589-596.
    PubMed     Text format     Abstract available

  64. KUMAR A, Hurtt CC, Cliby WA, Martin JR, et al
    Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses.
    Gynecol Oncol. 2017;147:514-520.
    PubMed     Text format     Abstract available

  65. REISER E, Aust S, Seebacher V, Reinthaller A, et al
    Preoperative C-reactive protein serum levels as a predictive diagnostic marker in patients with adnexal masses.
    Gynecol Oncol. 2017;147:690-694.
    PubMed     Text format     Abstract available

  66. BOULAY E, Galczynski K, Canis M, Bourdel N, et al
    Laparoscopic pelvic lymphadenectomy in 10 steps - let's make it easier!
    Gynecol Oncol. 2017;145:217-218.
    PubMed     Text format    

  67. NAROD SA, Sopik V, Giannakeas V
    Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.
    Gynecol Oncol. 2016 Feb 25. pii: S0090-8258(16)30044.
    PubMed     Text format    

  68. ALVAREZ RD, Matulonis UA, Herzog TJ, Coleman RL, et al
    Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer.
    Gynecol Oncol. 2016 Apr 3. pii: S0090-8258(16)30063.
    PubMed     Text format    

  69. NAROD SA
    Talc and ovarian cancer.
    Gynecol Oncol. 2016 Apr 16. pii: S0090-8258(16)30139.
    PubMed     Text format    

  70. ZHU J, Chen Z, Yong L
    Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
    Gynecol Oncol. 2017 Nov 27. pii: S0090-8258(17)31538.
    PubMed     Text format     Abstract available

  71. KIM HS, Lee M
    Video endoscopic inguinal lymphadenectomy (VEIL) for vulvar cancer.
    Gynecol Oncol. 2017;144:225-226.
    PubMed     Text format    

  72. MURALI R, Grisham RN, Soslow RA
    The roles of pathology in targeted therapy of women with gynecologic cancers.
    Gynecol Oncol. 2017 Nov 23. pii: S0090-8258(17)31530.
    PubMed     Text format     Abstract available

  73. KITSON SJ, Lindsay J, Sivalingam VN, Lunt M, et al
    The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study.
    Gynecol Oncol. 2017 Nov 24. pii: S0090-8258(17)31529.
    PubMed     Text format     Abstract available


    Hum Reprod

  74. ROMAN H, Bubenheim M, Huet E, Bridoux V, et al
    Conservative surgery versus colorectal resection in deep endometriosis infiltrating the rectum: a randomized trial.
    Hum Reprod. 2017 Nov 29:1-11. doi: 10.1093.
    PubMed     Text format     Abstract available

  75. BISHOP CV, Mishler EC, Takahashi DL, Reiter TE, et al
    Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
    Hum Reprod. 2017 Nov 28:1-12. doi: 10.1093.
    PubMed     Text format     Abstract available

  76. LIN AW, Dollahite JS, Sobal J, Lujan ME, et al
    Health-related knowledge, beliefs and self-efficacy in women with polycystic ovary syndrome.
    Hum Reprod. 2017 Nov 22:1-10. doi: 10.1093.
    PubMed     Text format     Abstract available

  77. LABARTA E, Mariani G, Holtmann N, Celada P, et al
    Corrigendum: Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study.
    Hum Reprod. 2017 Nov 21:1. doi: 10.1093.
    PubMed     Text format    


    Int J Cancer

  78. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    PubMed     Text format     Abstract available

  79. REIMER D, Boesch M, Wolf D, Marth C, et al
    Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
    Int J Cancer. 2017 Dec 1. doi: 10.1002/ijc.31186.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  80. MATSUZAKI S, Yoshino K, Endo M, Kakigano A, et al
    Conservative management of placenta percreta.
    Int J Gynaecol Obstet. 2017 Nov 30. doi: 10.1002/ijgo.12411.
    PubMed     Text format     Abstract available

  81. HUBINONT C, Mhallem M, Baldin P, Debieve F, et al
    A clinico-pathologic study of placenta percreta.
    Int J Gynaecol Obstet. 2017 Nov 30. doi: 10.1002/ijgo.12412.
    PubMed     Text format     Abstract available

  82. ATALLAH D, Moubarak M, Nassar M, Kassab B, et al
    Case series of outcomes of a standardized surgical approach for placenta percreta for prevention of ureteral lesions.
    Int J Gynaecol Obstet. 2017 Nov 27. doi: 10.1002/ijgo.12402.
    PubMed     Text format     Abstract available


    JAMA

  83. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


    Lancet

  84. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    PubMed     Text format     Abstract available

  85. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    PubMed     Text format    

  86. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed     Text format    


    Obstet Gynecol


  87. Committee Opinion No. 726: Hospital Disaster Preparedness for Obstetricians and Facilities Providing Maternity Care.
    Obstet Gynecol. 2017;130:e291-e297.
    PubMed     Text format     Abstract available

  88. MCLEOD C, Samelson R
    Placental Abruption With Delayed Fetal Compromise in Maternal Acetaminophen Toxicity.
    Obstet Gynecol. 2017;130:1385.
    PubMed     Text format    

  89. BUTWICK AJ, Deneux-Tharaux C, Sentilhes L
    Tranexamic Acid for the Management of Obstetric Hemorrhage.
    Obstet Gynecol. 2017;130:1386.
    PubMed     Text format    


  90. Committee Opinion No. 726 Summary: Hospital Disaster Preparedness for Obstetricians and Facilities Providing Maternity Care.
    Obstet Gynecol. 2017;130:1397-1398.
    PubMed     Text format     Abstract available


    Oncogene

  91. ZHONG Y, Yang J, Xu WW, Wang Y, et al
    KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
    Oncogene. 2017;36:6177-6189.
    PubMed     Text format     Abstract available


    PLoS One

  92. SPARAGANA S, Franz DN, Krueger DA, Bissler JJ, et al
    Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex.
    PLoS One. 2017;12:e0186235.
    PubMed     Text format     Abstract available

  93. HARTER P, Hauke J, Heitz F, Reuss A, et al
    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
    PLoS One. 2017;12:e0186043.
    PubMed     Text format     Abstract available

  94. XU Y, Zhao W, Li T, Zhao Y, et al
    Effects of acupuncture for the treatment of endometriosis-related pain: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186616.
    PubMed     Text format     Abstract available

  95. CHESNAIS M, Lecuru F, Mimouni M, Ngo C, et al
    A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
    PLoS One. 2017;12:e0187245.
    PubMed     Text format     Abstract available

  96. CLARK JL, Perez-Brumer AG, Segura ER, Salvatierra HJ, et al
    Anticipated Notification of Sexual Partners following STD Diagnosis among Men Who Have Sex with Men and Transgender Women in Lima, Peru: A Mixed Methods Analysis.
    PLoS One. 2016;11:e0163905.
    PubMed     Text format     Abstract available


    Radiology

  97. GEE MS, Atri M, Bandos AI, Mannel RS, et al
    Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
    Radiology. 2017 Nov 29:170963. doi: 10.1148/radiol.2017170963.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: